• Login
    View Item 
    •   Shocker Open Access Repository Home
    • Graduate Student Research
    • ETD: Electronic Theses and Dissertations
    • Dissertations
    • View Item
    •   Shocker Open Access Repository Home
    • Graduate Student Research
    • ETD: Electronic Theses and Dissertations
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Pre-clinical treatment of skin cancer by magnetic-protein nanocomposite drug delivery system

    View/Open
    d11030_Misak.pdf (17.84Mb)
    Date
    2011-12
    Author
    Misak, Heath Edward
    Advisor
    Asmatulu, Ramazan
    Metadata
    Show full item record
    Abstract
    Skin cancer affects many people worldwide and is life threatening without treatment. People with light skin, genetic diseases, and high exposure to ultraviolet radiation (UVR) are at a high risk of developing skin cancer. Once developed, skin cancer can spread to the rest of the body, including organs inside the body. If the cancer is established, it is difficult to control and treat. Skin cancer is diagnosed by the depth at which it has spread below the skin. Conventional treatments such as creams and lotions treat only the outer skin surface, while cancer below the skin is allowed to thrive. Treating only the outer layer and not the inner layer of skin can make it difficult to diagnose cancer because the severity of it can be hidden. The ideal treatment is to treat cancer from the inside out. Administering common cancer medicines means killing healthy cells as well as cancer cells; therefore, developing a drug delivery system (DDS), which can be injected into the body and release medicine at an engineered rate and location, is needed. In this thesis, a special drug delivery system is proposed—one that lessens the toxicity of a therapeutic agent from an intraperitoneal (IP) injection by reducing diffusion of that injection into sensitive areas of the body. This DDS uses both magnetic forces to hold it at the affected location and also a protein, encapsulated into the DDS, to reduce an immune response. The protein can also encourage uptake of the DDS into the cancer cell where the DDS releases the therapeutic agent. It is shown that this DDS is successful in treating cancer, and no toxic effects were found, which makes this treatment a possible alternative to conventional therapies.
    Description
    Thesis (Ph.D.)--Wichita State University, College of Engineering, Dept. of Mechanical Engineering
    URI
    http://hdl.handle.net/10057/5152
    Collections
    • CE Theses and Dissertations
    • Dissertations
    • ME Theses and Dissertations

    Browse

    All of Shocker Open Access RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsBy TypeThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace software copyright © 2002-2023  DuraSpace
    DSpace Express is a service operated by 
    Atmire NV